World Summit of Antivirals--BIT Life Sciences' First Annual Summit. Combating severe viral infections

IDrugs. 2008 Oct;11(10):716-9.
No abstract available

Publication types

  • Congress

MeSH terms

  • AIDS Vaccines / therapeutic use
  • Administration, Intranasal
  • Administration, Intravaginal
  • Animals
  • Anti-Infective Agents, Local / therapeutic use
  • Antibodies / administration & dosage
  • Antibodies / therapeutic use*
  • Antiviral Agents / administration & dosage
  • Antiviral Agents / chemistry
  • Antiviral Agents / therapeutic use*
  • Cellulose / analogs & derivatives
  • Cellulose / therapeutic use
  • Chemistry Techniques, Analytical
  • Copper / therapeutic use
  • Drug Design
  • HIV Infections / drug therapy
  • HIV Infections / virology
  • HIV-1 / drug effects
  • HIV-1 / immunology
  • Herpes Simplex / drug therapy
  • Herpes Simplex / virology
  • Herpesvirus 2, Human / drug effects
  • Humans
  • Influenza A Virus, H5N2 Subtype / immunology
  • Japanese Encephalitis Vaccines / therapeutic use
  • Oligosaccharides / therapeutic use
  • Poxviridae / immunology
  • Severity of Illness Index
  • Vaccines, Attenuated / therapeutic use
  • Vaccines, DNA / therapeutic use
  • Viral Vaccines / administration & dosage
  • Viral Vaccines / chemistry
  • Viral Vaccines / therapeutic use*
  • Virus Diseases / drug therapy*
  • Virus Diseases / transmission
  • Virus Diseases / virology

Substances

  • AIDS Vaccines
  • Anti-Infective Agents, Local
  • Antibodies
  • Antiviral Agents
  • Japanese Encephalitis Vaccines
  • Oligosaccharides
  • Vaccines, Attenuated
  • Vaccines, DNA
  • Viral Vaccines
  • cellulose acetate 1,2-benzenedicarboxylate
  • Copper
  • Cellulose
  • cupric oxide